BFBIO logo

BF Biosciences Limited Stock Price

KASE:BFBIO Community·PK₨12.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 15 Fair Values set on narratives written by author

BFBIO Share Price Performance

PK₨138.86
-33.21 (-19.30%)
PK₨138.86
-33.21 (-19.30%)
Price PK₨138.86

BFBIO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with proven track record.

1 Risk
1 Reward

BF Biosciences Limited Key Details

PK₨8.2b

Revenue

PK₨4.9b

Cost of Revenue

PK₨3.3b

Gross Profit

PK₨2.7b

Other Expenses

PK₨598.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
6.78
40.29%
7.28%
32.5%
View Full Analysis

About BFBIO

Founded
2006
Employees
535
CEO
Muhammad Rafiq
WebsiteView website
bfbio.com

BF Biosciences Limited, a biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products in Pakistan, Nepal, Afghanistan, Mauritania, Switzerland, and internationally. The company offers pharmaceutical products for various therapeutic areas, including cardiometabolic disorders, cardiology, diabetes, anti-obesity, hepatology, gastroenterology, chronic kidney diseases, dermatology, antifungal treatments, antibiotics, antivirals, rheumatoid arthritis, nephrology, and oncology. It also provides injectables in vials, ampoules, and pre-filled syringes forms. In addition, the company is involved in the sale of medical devices; and toll manufacturing services for pharmaceutical products to other pharmaceutical companies. It exports its products. The company was incorporated in 2006 and is headquartered in Lahore, Pakistan. BF Biosciences Limited is a subsidiary of Ferozsons Laboratories Limited.

Recent BFBIO News & Updates

Recent updates

No updates

BF Biosciences Limited Competitors